🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1 study to assess the safety and immunogenicity of differen...
Status
Completed
Location
Josha Research
Start Date
2022-05-30
Trial ID
NCT05228314
The purpose of the study is to evaluate the safety and immunogenicity of th...
Status
Terminated
Location
Medical Centre of Edelweiss Medics LLC
Start Date
2021-11-12
Trial ID
NCT05012787
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of the...
Status
Completed
Location
Las Piñas Doctors Hospital
Start Date
2022-06-13
Trial ID
NCT05188677
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of SCB...
Status
Withdrawn
Location
Health Index Multispecialty Clinic
Start Date
2023-08-17
Trial ID
NCT05926440
This is a phase 2/3, randomized, controlled study to assess the reactogenic...
Status
Withdrawn
Location
Clínica de la Costa Ltda
Start Date
2022-10-05
Trial ID
NCT05193279
Treatments Being Tested
This is a phase 2, randomized, controlled, observer-blind study to evaluate...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-08
Trial ID
NCT04950751
Treatments Being Tested
This is a randomized, double blind, placebo controlled, first-in-human (FIH...
Status
Completed
Location
Linear Clinical Research Ltd
Start Date
2020-06-19
Trial ID
NCT04405908
This is an exploratory phase 3, cohort randomized, observer-blind, multi-ce...
Status
Unknown
Location
Centro de Estudos e Pesquisa em Moléstias Infecciosas (CEPCLIN)
Start Date
2022-08
Trial ID
NCT05470803
Treatments Being Tested
SARS-CoV-2 is a highly transmissible and pathogenic coronavirus that emerge...
Status
Unknown
Location
Hospital de Clínicas de Porto Alegre
Start Date
2021-12-01
Trial ID
NCT05087368
The purpose of this study is to assess the immunogenicity and safety of SCB...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT06567457